IP Library Granted Patent US 11,464,459
Granted Patent B2
US 11,464,459 · App. 16/218,135 · Granted Oct 11, 2022

User interface for diabetes management systems including flash glucose monitor

Inventors: John Sjolund (Los Altos, CA); Ambika Srinath (San Francisco, CA); Andrew Bochenko (Redwood City, CA); George Crothall (Oceanside, CA); Bryan Mazlish (Palo Alto, CA); Jennifer Martin Block (Menlo Park, CA); Sarah Matarese (Milpitas, CA); Linda Mackowiak (Cazenovia, NY); Lane Desborough (Thousand Oaks, CA)
Assignee: Bigfoot Biomedical, Inc.
A61B5/743A61B5/14503A61B5/14532G16H20/17G16H40/67A61B5/0002A61B5/6898
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,459
App. No.
16/218,135
Granted
Oct 11, 2022
Kind
B2
Abstract

One or more embodiments of the disclosure relate, generally, to a diabetes management system. Such a diabetes management system may include a flash glucose monitor and a user interface. The user interface may be configured to display one or more of graphical representations of glucose values and value representative of glucose measurements, and to change values displayed responsive to user interaction with the user interface.

Claims (43)

1. A diabetes management system comprising:

a flash glucose monitor adapted to be secured to a person with diabetes (PWD), the flash glucose monitor comprising:

a sensing portion adapted to detect glucose measurement data at regular time intervals, the regular time intervals being less than or equal to every 15 minutes; and

a wireless communication interface adapted to transmit glucose measurement data when the wireless communication interface is activated by a user, wherein the transmitted glucose measurement data for each wireless communication transmission comprises a glucose measurement data collected over a data transmission window of at least 1 hour; and

a user interface device comprising:

a UI wireless communication interface adapted to receive the transmitted glucose measurement data at irregular intervals governed at least in part by the actions of the user;

a display comprising a touch screen; and

a processor and memory, the processor being adapted to execute instructions in the memory to display a representation of glucose values comprising:

a graphical representation having:

a graph area having upper and lower boundaries;

a time axis presented along the upper boundary of the graph area of the graphical representation;

a glucose value axis presented along a lateral side of the graph area of the graphical representation;

a current time of the day presented on the graphical representation;

a plurality of previous glucose value markers presented for each time of the day prior to current time of the day for which glucose values have been received;

a most recent glucose value marker that is visually distinct from the plurality of previous glucose value markers,

a trend line connecting the plurality of previous glucose value markers, wherein the trend line extends at least to the current time of day and to the most recent glucose value marker, wherein the previous glucose value markers are visually distinct from the trend line;

a single numerical value representing a single glucose measurement adjacent to the graphical representation;

a button below the trend line, wherein, responsive to a user action selecting the button, the processor and memory are configured to query the flash glucose monitor to measure a lifespan of the sensing portion of the flash glucose monitor; and

a meter extending circumferentially around the button and indicating the lifespan of the sensing portion of the flash glucose monitor,

wherein both of the button and the meter extend partially into the graph area from the lower boundary and overlay a portion of the graph area;

wherein the single numerical value is the most recent glucose value when the screen is not being touched by a user, wherein the processor and memory are configured to change the single numerical value to a prior glucose value when a user touches a portion of the screen corresponding to a prior time of day on the graphical representation.

2. The diabetes management system of claim 1 , wherein the graphical representation comprises a point indicator that is positioned along the time axis to correspond to the time of day when the single numerical value was detected.

3. The diabetes management system of claim 2 , wherein the display is configured so that the user can change the position of the point indicator by pressing the portion of the screen corresponding to position along the time axis at a time prior to the most recent glucose value.

4. The diabetes management system of claim 1 , wherein the portion of the screen corresponding to the prior time of day is a portion of the screen depicting the time axis.

5. The diabetes management system of claim 1 , wherein the portion of the screen corresponding to the prior time of day is a portion of the screen depicting the curve of glucose values.

6. The diabetes management system of claim 1 , wherein a point indicator is moved along the graphical representation when the user touches the screen on the point indicator and slides the point indicator along the graphical representation.

7. The diabetes management system of claim 1 , wherein a point indicator moves back along the curve of glucose values to the most recent glucose value after the user stops pressing a portion of the graphical representation.

8. The diabetes management system of claim 1 , wherein the display further depicts a trend arrow adjacent to the single numerical value depicting a rate of change of glucose values at the time of the single numerical value.

9. The diabetes management system of claim 1 , further comprising a reusable accessory adapted to be reversibly secured to an insulin injection pen, wherein the reusable accessory comprises an accessory wireless communication interface adapted to be used by a user to interrogate the flash glucose monitor to receive the glucose measurement data.

10. The diabetes management system of claim 9 , wherein the accessory wireless communication interface is adapted to automatically transmit the glucose measurement data to the user interface device.

11. The diabetes management system of claim 9 , wherein the reusable accessory is adapted to detect an event associated with an administration of insulin from the insulin injection pen.

12. The diabetes management system claim 11 , further comprising displaying an injection indicator along the time axis of the graphical representation for each detected event.

13. The diabetes management system of claim 12 , wherein the injection indicator displays an amount of insulin administered.

14. The diabetes management system of claim 12 , wherein the injection indicator displays a type of insulin administered.

15. The diabetes management system of claim 14 , further comprising a second reusable accessory adapted to be reversibly secured to a second insulin injection pen, the second insulin injection pen retaining a second type of insulin, wherein the graphical representation includes different injection indicators along the time axis for each reusable accessory.

16. The diabetes management system of claim 9 , wherein the reusable accessory is a replacement pen cap and the event associated with an administration of insulin from the insulin injection pen is a capping or decapping of the replacement pen cap from the insulin injection pen.

17. The diabetes management system of claim 9 , wherein the reusable accessory comprises an accessory display, the accessory display depicting a most recent glucose value received from the flash glucose monitor.

18. The diabetes management system of claim 17 , wherein the user interface device is adapted to receive insulin therapy settings and wirelessly communicate the insulin therapy settings to the reusable accessory, wherein the accessory display is adapted to provide a recommended insulin dose based on the received insulin therapy settings and a most recent glucose value.

19. The diabetes management system of claim 1 , further comprising a blood glucose meter in wireless communication with one or more components of the system, wherein the graphical representation also includes BGM indicators representing blood glucose measurements from the blood glucose meter.

20. The diabetes management system of claim 19 , wherein the single numerical value representing a single blood glucose measurement is adapted to depict the blood glucose measurements from the blood glucose meter or blood glucose values from the flash glucose monitor.

21. A system of claim 1 , wherein the glucose measurement data and/or glucose values are an interstitial fluid glucose level or based on an interstitial fluid glucose level.

22. A system of claim 1 , wherein the glucose measurement data and/or glucose values are a blood glucose level correlated to an interstitial fluid glucose level.

23. A system of claim 1 , wherein the glucose measurement data and/or glucose values are a blood glucose level.

Assignments (19)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069870/0588 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069071/0980 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
RELEASE OF SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069030/0157 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069019/0346 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068948/0377 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
RELEASE OF SECURITY INTEREST Recorded Sep 26, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 065029/0271 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2020
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA; DESBOROUGH, LANE
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 052746/0512 →
Cited By (4)
US 1,137,686 US 12,576,212 US 12,616,426 US 12,629,106